Breast cancer risk: What is the PALB2 gene mutation? Expert weighs in

breast cancer risk what is the palb2 gene mutation expert weighs in

Sumary of Breast cancer risk: What is the PALB2 gene mutation? Expert weighs in:

  • BRCA gene mutations are well known indicators of a person’s risk for breast cancer, however the PALB2 mutation is the third most prevalent breast cancer gene experts say people should be aware of in determining risk for developing the disease.
  • Researchers have linked the PALB2 gene mutation to diseases like breast, ovarian and pancreatic cancers, medical experts told Fox News.
  • Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) gene mutations are the top two mutations highly associated with inherited cancers such as breast and ovarian cancer, as well as pancreatic, prostate and melanoma cancers.
  • PACIFIC YEW: A POTENT CANCER FIGHTING AGENTDr. Elisa Port, chief of breast surgery at Mount Sinai Health System, told Fox News that the BRCA and PALB2 gene mutations do share similar risks, yet differ.
  • According to Port, who also serves as the director of the Dubin Breast Center at Tisch Cancer Institute at Mount Sinai, the risk of ovarian cancer with BRCA can be up to 20% or 40% depending on the BRCA gene.
  • According to the National Breast Cancer Foundation, family history plays a significant role in breast cancer risk, and researchers are helping to identify genes responsible for the increased risk of inheriting diseases.
  • A normal healthy gene decreases one’s risk of developing breast cancer, NBCF explains on its webpage.
  • However, the risk increases if the gene is abnormal, hampering its ability to perform its role to prevent cancer in the body.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.